18p- syndrome and hypopituitarism.
A patient is described with 18p- syndrome and hypopituitarism. This is the first patient with this syndrome who has been shown to benefit from growth hormone therapy. Patients with this syndrome who have growth deficiency should be considered for evaluation for hypopituitarism, if the quality of their lives would improve with an increase in stature.
Artman
H G
HG
Department of Pediatrics, University of Nevada School of Medicine, Reno 89557.
Morris
C A
CA
Stock
A D
AD
D000015:Abnormalities, Multiple / Q000235:genetics*; D002675:Child, Preschool; D002887:Chromosomes, Human, Pair 18 / Q000648:ultrastructure*; D002891:Chromosomes, Human, Pair 21 / Q000648:ultrastructure*; D004393:Dwarfism, Pituitary / Q000188:drug therapy / Q000235:genetics*; D013006:Growth Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D019382:Human Growth Hormone; D006801:Humans; D007018:Hypopituitarism / Q000235:genetics*; D007859:Learning Disabilities / Q000235:genetics; D008297:Male; D014178:Translocation, Genetic
D019382:Human Growth Hormone; D013006:Growth Hormone